213 findings · Neural · published 2022+
- NeuralStrong
Exercise selection and rest interval length influence the rating of discomfort, with leg extensions producing less discomfort than back squats.
Selecting exercises with lower perceived discomfort may enhance training adherence.
Supports 2023 - NeuralStrong
GLP-1 receptor agonists suppress appetite and food reward to elicit rapid weight loss.
Practitioners can consider GLP-1 receptor agonists as effective options for weight loss.
Supports 2024 - NeuralStrong
The vasti, soleus, and gluteus maximus generated the largest upward accelerations of the center of mass during the barbell back squat.
Strength coaches should focus on training the vasti, soleus, and gluteus maximus for improved squat performance.
Supports 2023 - NeuralStrong
Muscle function during squatting is task and posture specific, depending on joint position and environmental interaction.
Practitioners should consider joint positions and task-specific demands when designing squat training programs.
Supports 2023 - NeuralStrong
Lifestyle recommendations for nutritional care and physical activity in diabetes management are poorly implemented.
Practitioners should enhance the implementation of lifestyle interventions in diabetes care.
Supports 2025New - NeuralStrong
Participants improved their accuracy in estimating repetitions in reserve (RIR) during the bench press over the intervention.
Improving RIR estimation can enhance training effectiveness and safety.
Supports 2025New - NeuralStrong
Long-term intake of UPFs leads to addiction due to additives including fat, caffeine, and sugar.
Health professionals should consider the addictive potential of UPFs when advising clients.
Supports 2025New - NeuralStrong
Powerlifters had significantly greater training duration and absolute squat and bench press 1RM compared to recreationally strength-trained subjects.
Powerlifting training may lead to greater strength gains compared to recreational strength training.
Supports 2022 - NeuralStrong
Significant negative relationships were found between 2-lift Wilks score and shoulder extension and horizontal abduction, as well as hip flexion and extension.
Improving shoulder and hip ROM may enhance strength performance in powerlifters.
Supports 2022 - NeuralStrong
There was a significant main effect for time on raw RIRDIFF, indicating a slight decrease in raw RIRDIFF over time.
Trainers may observe that RIR predictions become slightly more accurate over time with consistent training.
Supports 2023 - NeuralStrong
There was a greater tendency to underestimate RIR in later sessions and during higher repetition sets.
Coaches should be aware that athletes may underestimate their RIR as training progresses.
Qualifies 2023 - NeuralStrong
The preoperative weight loss intervention was feasible and viewed favorably among patients, with 83% feeling that video calls were helpful.
Practitioners can consider using video consultations as a supportive tool for weight loss interventions.
Supports 2025New - NeuralStrong
The unique combination of naltrexone and bupropion in NB-ER may work together to target POMC cells to prevent endogenous negative feedback, thereby decreasing appetite.
Understanding the mechanism can help practitioners explain the treatment's effects to patients.
Supports 2025New - NeuralStrong
Both groups experienced similar improvements in knee extension one-repetition maximum (1RM) after 12 weeks of ST (LOV: 24.7 ± 11.1 kg; NV: 21.6 ± 9.8 kg).
Strength training can enhance strength performance similarly in both vegetarians and non-vegetarians.
Supports 2023 - NeuralStrong
Patients showed improvements in mental health scores, with SF-12 mental scores changing by 2.8 points at 6 months and 2.3 points at 18 months.
Improving mental health is a crucial component of lifestyle interventions for obesity.
Supports 2023 - NeuralStrong
The intervention showed a significant reduction in depression scores in the ACTIVE group compared to the CON group.
Implementing online exercise programs may help reduce depression in older adults.
Supports 2023 - NeuralStrong
There was stronger support for general inter-individual response variation (GEN) compared to condition-specific response variation (CON).
Understanding general response variation can help tailor training programs more effectively.
Supports 2025New - NeuralStrong
If the BB-Health protocol demonstrates feasibility, the MCNS with and without WL intervention has potential to prevent age-related cognitive decline.
Practitioners may consider the implications of MCNS and WL interventions for cognitive health in older adults.
Conditional 2024 - NeuralStrong
GLP-1 agonists can modulate appetite through effects on the hypothalamus, making them promising for obesity treatment.
GLP-1 agonists may be effective options for patients looking to manage obesity through appetite control.
Supports 2025New - NeuralStrong
Acute data generally show that muscle activation and training volume do not differ between supersets and traditional resistance training.
Both training methods can be considered equally effective in terms of muscle activation and volume.
Supports 2025New - NeuralStrong
Family member participation in the intervention expands the possibilities for lasting lifestyle changes.
Encouraging family involvement can enhance the effectiveness of obesity treatment programs.
Supports 2022 - NeuralStrong
Novel study designs can account for confounding sources of variation in individual response to resistance training.
Practitioners can use these study designs to better understand individual training responses.
Supports 2023 - NeuralStrong
Use of incretin-based therapies (IBT) after bariatric surgery is associated with a 55% lower risk of new-onset alcohol use disorder (AUD) compared to non-IBT antiobesity medications (AOMs).
Practitioners may consider prescribing IBT for patients post-bariatric surgery to reduce the risk of AUD.
Supports 2025New - NeuralStrong
IBT is associated with a 41% lower risk of initiation of medications for alcohol use disorder (MAUDs) compared to non-IBT AOMs.
IBT may be a beneficial option for reducing the need for MAUDs in post-bariatric surgery patients.
Supports 2025New